report banner

News in English

PostNews: Press Release

PHI and BioSpherix sign co-marketing agreement

Phase Holographic Imaging (PHI) and BioSpherix recently signed a collaboration agreement aiming to co-market the companies’ complementary product lines. BioSpherix, NY USA, manufactures and markets advanced cell incubators.
Learn more …
PostNews

Biostock interview with CEO Peter Egelberg

Learn more …
PostNews
QUT_scientists_HoloMonitor_Twitter

New CEO commentary — “Redefining aging with HoloMonitor”

In the CEO commentary “Redefining aging with HoloMonitor” Peter Egelberg comments on the promising research results that were recently reported by Australian television.
Learn more …
PostNews

PHI at the Nordic Microscopy Society meeting, June 25-28

The Nordic Microscopy Society meeting in Lyngby Denmark offers several opportunities to meet with us and to hear about the latest HoloMonitor news.
Learn more …
PostPress Release

Notice of Extraordinary General Meeting in Phase Holographic Imaging PHI AB (publ)

Notice to the shareholders in Phase Holographic Imaging AB (publ), 556542-7811, to attend an Extraordinary General Meeting on Monday June 18 at 06.00 PM (18.00) at PHI’s office, Scheelevägen 22, Lund.
Learn more …
PostNews: Press Release

Decision on rights issue for continued growth, establishment of sales organization and commercial break-through

The Board of directors of Phase Holographic Imaging PHI AB (publ) (”PHI”) has decided to conduct a rights issue of units, which is subject to approval on Extraordinary General Meeting, that can provide the company a total of SEK 64.6 million at the most prior to issuing costs.
Learn more …
1202122232433